Catalog |
name |
Description |
price |
R-R-0294 |
FAPI-09 |
FAPI-09/Fibroblast-activation-protein inhibitor-9 is a small molecule compound designed to target fibroblast activation protein (FAP), an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer. |
price> |
R-R-0295 |
FAPI-10 |
FAPI-10/Fibroblast-activation-protein inhibitor-10 is a small molecule compound designed to target fibroblast activation protein (FAP), an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer. |
price> |
R-R-0297 |
FAPI-12 |
FAPI-12/Fibroblast-activation-protein inhibitor-12 is a small molecule compound designed to target fibroblast activation protein (FAP), an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer. |
price> |
R-R-0298 |
FAPI-14 |
FAPI-14/Fibroblast-activation-protein inhibitor-14 is a small molecule compound designed to target fibroblast activation protein (FAP), an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer. |
price> |
R-R-0299 |
FAPI-15 |
FAPI-15/Fibroblast-activation-protein inhibitor-15 is a small molecule compound designed to target fibroblast activation protein (FAP), an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer. |
price> |
R-R-0300 |
FAPI-2 |
FAPI-2/Fibroblast-activation-protein inhibitor-2/CAS .2370952-98-8
is a small molecule compound designed to target fibroblast activation protein (FAP), an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer. |
price> |
R-R-0301 |
Fmoc-FAPI-4 |
Fmoc-FAPI-4 is a specific fibroblast activation protein inhibitor (FAPI) compound that is a member of the FAPI family of molecules. Fmoc-FAPI-4, like other FAPI compounds, is intended to selectively accumulate in FAP-positive tumors and disrupt the functions of cancer-associated fibroblasts (CAFs) in the tumor microenvironment. By inhibiting FAP activity, these compounds aim to potentially slow down tumor growth, enhance the efficacy of other cancer treatments, and modulate the tumor microenvironment. |
price> |
R-R-0302 |
SH-FAPI-4 |
SH-FAPI-4 is a specific fibroblast activation protein inhibitor (FAPI) compound that belongs to the FAPI family of molecules. SH-FAPI-4 is expected to selectively accumulate in FAP-positive tumors and disrupt the functions of cancer-associated fibroblasts (CAFs) within the tumor microenvironment. By inhibiting FAP activity, this compound aims to potentially slow tumor growth, enhance the efficacy of other cancer treatments, and modulate the tumor microenvironment. |
price> |
R-R-0303 |
FAPI |
FAPI stands for fibroblast activation protein inhibitor. FAPI compounds are a class of small molecule inhibitors designed to target and inhibit fibroblast activation protein (FAP). FAP is an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer. |
price> |
R-R-0304 |
UAMC1110 |
UAMC-1110, also known as SP-13786, is a novel potent and selective inhibitor of fibroblast activation protein (fap), displaying low nanomolar inhibitory potency and high selectivity against the related dipeptidyl peptidases (dpps) dppiv, dpp9, dppii, and prolyl oligopeptidase (prep). |
price> |